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Despite extensive knowledge in the medical field, used canapes (Cannabis Sativa) is rather limited, despite its 
history of thousands of years, which shows that knowledge about its therapeutic potential are still insufficient. 
Problems related to the illegal status of cannabis, are the side effects of its therapeutic use. There are numerous 
drugs with great risk to create dependence; however, there are regularly described recipes. From the medical point 
of view the introduction of some cannabis derivatives as drugs that can not be recommended by prescription is 
wrong. A 96 year study showed clear therapeutic efficacy cannabis in several pathologies and that criticism about 
therapeutic cannabis ability, and especially TCH, were superficial, general and without any proof. So take into 
consideration the conditions in which cannabis products can be used safely. In addition to scientific data 
observations reported by patients who have resorted to the use of cannabis.For several years cannabis has become 
popular in terms of usage textile and precious edible oil obtained from its seeds, and its rediscovery as the curative 
substance causes turmoil and controversy. 
 
Active components 
Significant, pharmacological substances are the canabinoids, found in plants of Cannabis sativa. 
We found plants, amino acids, proteins, glycoproteins, glucide, terpens, phenols, hydrocarbons, alcohols, aldehydes, 
ketones, fatty acids, vitamins, lakton and steroids. In 1980 E.Turner describes about 421 chemical compounds 
present in Cannabis Sativa. Also the amount of each of these components is in different amounts in different 
species. 
 
The cannabinoids 
More than 60 different types of natural cannabinoids are recognized today. Among the main ones: 
Δ-9-tetrahidrocannabinoli (Δ-9-THC, or February THC) that acts as miorelaxant, antiepileptic, humor tonic, 
antibiotic, antipyretic and lowers intraocular pressure, bronchodilators. 
Abstract: Cannabis sativa - a very curved name, often as a synonym for evil. Known and used since Antiquity, in almost all arts 
of the world, for medical purposes, but also industrial food today is questioned. Is it good or bad? Hard to say exactly! Called 
often as "killer plant", "plant cursed" in some cases has resulted in the "best" finding use in symptoms or pathology where 
known therapy has not been very effective. Purpose: According to published studies by many researchers, and some of the 
research on persons who have used hashish, some for pleasure and others for treating an illness (cancer and AIDS), may shed 
light on this very sensitive topic. Often combined with legal problems is not easy to give a final judgment. Method of study: 
The study is descriptive character. Conclusions: The data presented below suggest that there is enough space in which 
cannabinoids can be used effectively, but it has always and only for therapeutic purposes and without avoiding legal framework. 
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Cannabidioli (CBD) without psychotropic effects strengthens the sedative effects of THC. Also acts as antiepileptic, 
anxiolitic and intraocular pressure stabilizer. Canabidioli is second cannabinoids important of cannabis. Δ-9-THC 
is the main responsibility of the effect of intoxication. Cannabidioli antagonizon toxic effect caused by THC. So far 
it has been little studied and experimented only in animals. Other types cannabinoids are, cannabinoli (CBN), 
cannabigeroli (CBG), cannabicromi (CBC), Δ-8-THC, cannabicicloli (CBL), cannabitrioli (CBLT) cannabinodioli 
(CBND) etc., as well as their mixed form. 
 
Effects 
Cannabinoids act through receptors located in the cell membrane, creating with them a specific and reversible 
connection. In the early 90s was discovered anandamidi produced by the body that connects receptor cannabinoids. 
Natural Canabinnoids bind to the same receptor in the membrane of nerve cells. Strangely cannabinoids and 
anandamides have very different chemical structure. 
 
Receptors of cannabinoids 
In 1987 it was discovered the mechanism cannabinoids transport to receptors. In 1988 Devant and Johnson showed 
a specific cannabinoids receptor in mouse brain. Later it was discovered receptor cannabinoids in quite mamiferes 
and in humans. Besides brain receptor (CB1), were found in immune cells of spleen (CB2). Different 
Cannabinoids related in many different ways with CB1 or CB2. 
 
Scope 
Paul Consroe and Reuven Sandyk in 1992 showed therapeutic effects cannabinoids and neuropatiks neurological 
disorders (spasms, cramps, headaches, epilepsy). The most important component is THC which is regarded as a 
depressant, stimulant or halucinogen. The possibility of use of cannabis extracts and natural special cannabinoids 
refer mainly to: Lack of appetite (anorexia) and organic depression (kahexia) in AIDS and some types of tumors; 
Nausea in radiotherapy and chemotherapy and AIDS; Muscular spasms (in spinal cord injuries and multiple 
sclerosis); Pain condition (headache, tumor pain, neuropatiks, muscular, dismenorrhea) and Glaucoma.  
Other indications cannabinoids are Bronchial Asthma, epilepsy, depression, hypertension, fever, dysentery. 
Antibiotic potential of cannabis can be used especially in the preparation of ointments. 
 
Improve the tone of humor 
Cannabis intoxication brings decrease of physical and mental suffering, contributing to the facilitation of relations 
with them disease. The question "why exactly I", are inevitable to the patients. desiring to live and the courage to 
face the disease, reflected in a positive manner during the course of many diseases, and despair does not 
nonetheless aggravate the situation. Walton published a series of experiences with hashish among which that of a 
doctor: After an hour developed a state of unspeakable miracle which was absolutely personal and fusion with the 
entire universe. The skin was moist, dry mouth, a wonderful color landscapes vision, stained image: blue, purple 
and was sorry I can not share with someone else this experience. In addition enter into a state of sleep and sleep 
until the usual hour. All the above feelings in the morning were disappeared. One user said: An hour after, a full 
sense of pleasure and wellbeing. Two hours later, a nasty feeling, followed by feeling nausea and vomiting, 
pathological fear of being watched by someone. Nearly three hours after he felt quite well and wake up from this 
state of lethargy. Following spent a nice night without consequence. 
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Cancer 
During the '70s there were used for the first time a combination of drugs for the treatment of cancer. After hundreds 
of clinical research today are achieving good results in the treatment of leukemia. We combined therapies are 
generally cytostatics, which recognize and kill tumor cells, but at the same time they kill healthy cells giving very 
severe side effects: hair fall, injury or cardiac, hepatic, renal, bone marrow, etc. Among the side effects of this 
therapy are nausea and vomiting, which should reduce the dose. But this reduces the effectiveness of the therapy, 
while the success is related to the delivery of standard doses. In some patients these side effects are so severe as 
leading to abandonment of therapy. In these cases, used different antiemetiks, but not always turn out to be 
effective. In 1975 published the first study that showed efficacy of THC against provoking vomiting from 
chemotherapy. In the USA in 1985 came on the market synthetic THC MARINOL against vomiting in 
chmioterapeutikal therapy. Pharmacological studies show that active components of cannabis can be used 
successfully in the treatment of vomiting from other causes. In the 80s in Germany became a study levanantradol 
where noted improvement in 17 of 20 patients, who previously did not respond to drugs antiemetiks. In 5 subjects 
symptoms disappeared immediately. In 1998 Vinciguerra with an experiment on 56 patients less sensitive to 
routine treatment, showed efficacy against marijuana in 44 cases. In 1995, in Israel were studied 8 children with 
various forms of cancers, who went under underwent preventive therapy with Δ-8-THC. 8 patients received 
relatively high doses of TCH, about 18mg/m2 body surface two hours prior to the use of chemotherapy and then 
after 6 hours. The vomit was opposed due to THC. In two children appeared lighter side effects. We believe that 
the improvement of the overall quality of life due to cannabis should serve as impetus in continuing research by 
researchers in relation to his antiemetiks effects. 
 
AIDS 
Persons affected by AIDS suffer weight loss due to nausea and reduction of appetite. Show that after taking 
cannabis patients feel the need to eat again. Medicines used in the treatment against the virus are often the cause of 
a strong state general deterioration, which often puts lives at risk. The increase in weight in very weak patients 
means to prolong life, as has been proven by various studies. Among other things cannabis improves mood and 
combats the possibility of decline in depressive condition, what positively affects the immune system. Results of a 
U.S. study published in 1991 showed the effectiveness of THC in stimulating appetite in patients affected by AIDS, 
only with doses of 5 mg per day. Before the start of treatment was seen a weight loss of about 0900 kg, while under 
the effect of THC pasha increased on average 1kg per month. Research conducted in 1995 by Beal in which 
participated 139 patients, led to the authorization use of Maronol, THC-based preparation of synthesis, even in 
patients affected by AIDS. For many years, is known efficacy of cannabis in stimulating appetite but should not be 
associated with a reduction in blood sugar level, as referred incorrectly before, but probably by a direct action on 
the central nervous system. A man 45 years old, HIV-positive indicates that he had learned to use therapeutic 
cannabis. THC was helping to cope with the side effects of anti-AIDS therapy. A female of 11 years old with 
HIV-positive indicated that after she learnt that she was carrying the virus, smokes hashish. If we understand that 
the dinner was not eaten all day, smokes 2 cigarettes sleep and when he woke up after 2-3 hours was hungry. 
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